Header cover image

Danish (OMX) Clinical Research and Equipment Industry Analysis

UpdatedNov 21, 2024
DataAggregated Company Financials
Companies2
  • 7D12.0%
  • 3M7.0%
  • 1Y117.2%
  • YTDn/a

The Clinical Research and Equipment industry is up 6.3% in the last week, with Gubra up 28%. This takes the industry's 12 month performance to a gain of 109%. Earnings are forecast to grow by 17% annually.

Industry Valuation and Performance

Has the Danish Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 21 Nov 2024DKK 17.8bDKK 631.7mDKK 89.8m57.2x198.8x28.2x
Sat, 19 Oct 2024DKK 14.6bDKK 631.7mDKK 89.8m56.2x163.1x23.2x
Mon, 16 Sep 2024DKK 16.2bDKK 631.7mDKK 89.8m58x180.3x25.6x
Wed, 14 Aug 2024DKK 16.0bDKK 606.5mDKK 99.3m45.7x161.4x26.4x
Fri, 12 Jul 2024DKK 16.7bDKK 606.5mDKK 99.3m44.8x167.9x27.5x
Sun, 09 Jun 2024DKK 11.6bDKK 606.5mDKK 99.3m40.2x116.6x19.1x
Tue, 07 May 2024DKK 10.3bDKK 606.5mDKK 99.3m36.3x103.3x16.9x
Thu, 04 Apr 2024DKK 11.6bDKK 606.5mDKK 99.3m47x116.8x19.1x
Sat, 02 Mar 2024DKK 12.1bDKK 605.1mDKK 136.8m61.4x88.2x19.9x
Mon, 29 Jan 2024DKK 9.1bDKK 647.9mDKK 171.7m40x53.1x14.1x
Wed, 27 Dec 2023DKK 8.9bDKK 647.9mDKK 171.7m38.3x51.7x13.7x
Fri, 24 Nov 2023DKK 8.2bDKK 647.9mDKK 171.7m35.2x47.5x12.6x
Sun, 22 Oct 2023DKK 6.4bDKK 647.9mDKK 171.7m27.3x37.4x9.9x
Tue, 19 Sep 2023DKK 8.5bDKK 647.9mDKK 171.7m37.3x49.5x13.1x
Thu, 17 Aug 2023DKK 9.3bDKK 660.6mDKK 184.0m225.3x50.4x14x
Sat, 15 Jul 2023DKK 9.1bDKK 660.6mDKK 184.0m197.7x49.7x13.8x
Mon, 12 Jun 2023DKK 10.3bDKK 660.6mDKK 184.0m206.6x56.1x15.6x
Wed, 10 May 2023DKK 8.6bDKK 660.6mDKK 184.0m223.3x46.5x12.9x
Fri, 07 Apr 2023DKK 6.5bDKK 461.2mDKK 179.7m36.3x36.3x14.1x
Sun, 05 Mar 2023DKK 7.7bDKK 461.2mDKK 179.7m43x43x16.7x
Tue, 31 Jan 2023DKK 10.3bDKK 428.4mDKK 159.5m64.6x64.6x24x
Thu, 29 Dec 2022DKK 12.2bDKK 428.4mDKK 159.5m76.7x76.7x28.5x
Sat, 26 Nov 2022DKK 14.7bDKK 428.4mDKK 159.5m92.1x92.1x34.3x
Mon, 24 Oct 2022DKK 11.2bDKK 428.4mDKK 159.5m70.4x70.4x26.2x
Wed, 21 Sep 2022DKK 12.3bDKK 428.4mDKK 159.5m77.1x77.1x28.7x
Fri, 19 Aug 2022DKK 14.7bDKK 358.0mDKK 131.3m112.1x112.1x41.1x
Sun, 17 Jul 2022DKK 12.8bDKK 358.0mDKK 131.3m97.2x97.2x35.6x
Tue, 14 Jun 2022DKK 13.2bDKK 358.0mDKK 131.3m100.2x100.2x36.7x
Thu, 12 May 2022DKK 12.2bDKK 358.0mDKK 131.3m92.8x92.8x34x
Sat, 09 Apr 2022DKK 15.1bDKK 358.0mDKK 131.3m115.1x115.1x42.2x
Mon, 07 Mar 2022DKK 13.3bDKK 358.0mDKK 131.3m101.5x101.5x37.2x
Wed, 02 Feb 2022DKK 12.1bDKK 281.1mDKK 88.4m136.8x136.8x43x
Fri, 31 Dec 2021DKK 14.5bDKK 281.1mDKK 88.4m164.1x164.1x51.6x
Sun, 28 Nov 2021DKK 16.0bDKK 281.1mDKK 88.4m181x181x56.9x
Price to Earnings Ratio

181x


Total Market Cap: DKK 16.0bTotal Earnings: DKK 88.4mTotal Revenue: DKK 281.1mTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Clinical Research and Equipment Industry Price to Earnings3Y Average 93.7x202220232024
Current Industry PE
    There are only 2 companies in the Danish Life Sciences Tools and Services industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 31% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Comparison

How does Danish Clinical Research and Equipment compare with similar industries?

DK Market-0.95%
Healthcare-2.40%
Life Sciences11.98%
Clinical Research and Equipment11.98%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

CHEMM

DKK 451.60

ChemoMetec

7D

-2.3%

1Y

25.1%

GUBRA

DKK 606.00

Gubra

7D

-11.7%

1Y

425.9%